Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Lipid nanoparticles (LNP) induce activation and maturation of antigen presenting cells in young and aged individuals
Jennifer Connors, David Joyner, Nathan Mege, et al.
Communications Biology (2023) Vol. 6, Iss. 1
Open Access | Times Cited: 53

Showing 1-25 of 53 citing articles:

Lipid nanoparticles (LNPs) for in vivo RNA delivery and their breakthrough technology for future applications
Michaela Jeong, Yeji Lee, Jeongeun Park, et al.
Advanced Drug Delivery Reviews (2023) Vol. 200, pp. 114990-114990
Closed Access | Times Cited: 87
Effect of mRNA-LNP components of two globally-marketed COVID-19 vaccines on efficacy and stability
Lizhou Zhang, Kunal R. More, Amrita Ojha, et al.
npj Vaccines (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 67
Recent advances in nanoparticulate RNA delivery systems
Jacob Witten, Yizong Hu, Róbert Langer, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 11
Open Access | Times Cited: 36
The immunostimulatory nature of mRNA lipid nanoparticles
Preeti Sharma, Daniek Hoorn, Anjaiah Aitha, et al.
Advanced Drug Delivery Reviews (2024) Vol. 205, pp. 115175-115175
Open Access | Times Cited: 34
Targeting lipid nanoparticles to the blood-brain barrier to ameliorate acute ischemic stroke
Jia Nong, Patrick M. Glassman, Vladimir V. Shuvaev, et al.
Molecular Therapy (2024) Vol. 32, Iss. 5, pp. 1344-1358
Open Access | Times Cited: 22
Direct in vivo CAR T cell engineering
Lauralie Short, Robert A. Holt, Pieter R. Cullis, et al.
Trends in Pharmacological Sciences (2024) Vol. 45, Iss. 5, pp. 406-418
Open Access | Times Cited: 15
Leveraging mRNA technology for antigen based immuno-oncology therapies
Charalampos S. Floudas, Siranush Sarkizova, Michele Ceccarelli, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 1, pp. e010569-e010569
Open Access | Times Cited: 1
mRNA vaccines: a new opportunity for malaria, tuberculosis and HIV
Laura Matarazzo, Paulo Bettencourt
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 35
Nucleic acid degradation as barrier to gene delivery: a guide to understand and overcome nuclease activity
Heyang Zhang, Jo Vandesompele, Kevin Braeckmans, et al.
Chemical Society Reviews (2023) Vol. 53, Iss. 1, pp. 317-360
Closed Access | Times Cited: 30
A holistic analysis of the intrinsic and delivery-mediated toxicity of siRNA therapeutics
Sheyda Ranjbar, Xiao‐bo Zhong, José E. Manautou, et al.
Advanced Drug Delivery Reviews (2023) Vol. 201, pp. 115052-115052
Open Access | Times Cited: 25
Emerging delivery approaches for targeted pulmonary fibrosis treatment
Rimpy Diwan, Himanshu Bhatt, Elfa Beaven, et al.
Advanced Drug Delivery Reviews (2023) Vol. 204, pp. 115147-115147
Open Access | Times Cited: 21
Lipid Nanoparticle-Associated Inflammation is Triggered by Sensing of Endosomal Damage: Engineering Endosomal Escape Without Side Effects
Serena Omo‐Lamai, Yufei Wang, Manthan N. Patel, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 13
Herpes zoster mRNA vaccine induces superior vaccine immunity over licensed vaccine in mice and rhesus macaques
Lulu Huang, Tongyi Zhao, Weijun Zhao, et al.
Emerging Microbes & Infections (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 10
Delivery of mRNA Encoding Interleukin-12 and a Stimulator of Interferon Genes Agonist Potentiates Antitumor Efficacy through Reversing T Cell Exhaustion
Bin Wang, Maoping Tang, Qijing Chen, et al.
ACS Nano (2024) Vol. 18, Iss. 24, pp. 15499-15516
Closed Access | Times Cited: 9
Expanding the Reach of Monoclonal Antibodies: A Review of Synthetic Nucleic Acid Delivery in Immunotherapy
Christopher Chung, Sagar B. Kudchodkar, Curtis N. Chung, et al.
Antibodies (2023) Vol. 12, Iss. 3, pp. 46-46
Open Access | Times Cited: 15
From Bench to Bedside: Implications of Lipid Nanoparticle Carrier Reactogenicity for Advancing Nucleic Acid Therapeutics
Tetiana Korzun, Abraham S. Moses, Parham Diba, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 8, pp. 1088-1088
Open Access | Times Cited: 15
Impact of physicochemical properties on biological effects of lipid nanoparticles: Are they completely safe
Ziyi Yuan, Ruyu Yan, Zuyi Fu, et al.
The Science of The Total Environment (2024) Vol. 927, pp. 172240-172240
Closed Access | Times Cited: 6
Recent Findings on Therapeutic Cancer Vaccines: An Updated Review
Sara Sheikhlary, David Humberto Lopez, Sophia Moghimi, et al.
Biomolecules (2024) Vol. 14, Iss. 4, pp. 503-503
Open Access | Times Cited: 6
Clinical perspective on topical vaccination strategies
Petya Popova, Sunny P. Chen, Suiyang Liao, et al.
Advanced Drug Delivery Reviews (2024) Vol. 208, pp. 115292-115292
Open Access | Times Cited: 5
Circular mRNA Vaccine against SARS-COV-2 Variants Enabled by Degradable Lipid Nanoparticles
Ke Huang, Na Li, Yingwen Li, et al.
ACS Applied Materials & Interfaces (2025)
Closed Access
Cytokine mRNA Delivery and Local Immunomodulation in the Placenta using Lipid Nanoparticles
Samuel Hofbauer, J. Lynn Fink, Rachel E. Young, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
Development of melittin-conjugated lipid nanoparticle (LNP-MEL) for mRNA-based respiratory syncytial virus (RSV) vaccination
Minyi Seo, Min‐Ho Lee, Yongwoo David Seo, et al.
Journal of Industrial and Engineering Chemistry (2025)
Closed Access
Identification of Cell Receptors Responsible for Recognition and Binding of Lipid Nanoparticles
Didar Baimanov, Jing Wang, Yuchen Liu, et al.
Journal of the American Chemical Society (2025) Vol. 147, Iss. 9, pp. 7604-7616
Closed Access
Surfactant protein B-derived peptides as endosomal escape enhancers for pulmonary delivery of siRNA
Lore Herman, Roberta Guagliardo, Agata Zamborlin, et al.
Journal of Controlled Release (2025)
Closed Access
An Industry Perspective on the Use of Novel Excipients in Lipid Nanoparticles—Nonclinical Considerations
Lorrene A. Buckley, Jessica E. Sutherland, Prachi Borude, et al.
International Journal of Toxicology (2025)
Closed Access
Page 1 - Next Page

Scroll to top